ArticleTrials2022

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID).

Pierre Malchair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.